Javascript er ikke aktivert i din nettleser. Dette er nødvendig for å bruke Oncolex. Kontakt din systemadministrator for å aktivere JavaScript.

Hodgkin's lymphoma

There are two main groups of Hodgkin's lymphoma (HL):

  • classical 
  • nodular lymphocyte-rich

Treatment of nodular lymphocyte-rich HL and classic HL differ to some extent. 

Almost 90% of patients are cured of HL. It is the combination of chemotherapies which has markedly improved the survival. Corticosteroids such as prednisolone are also used in many treatment schedules.

Previously, mostly radiation therapy was given for localized disease, however, this caused many long term side effects. Today, regimens are used in which chemotherapy are combined with smaller radiation fields and lower dosages. For stage III/IV HL, chemotherapy regimens are given.


Hodgkin lymphoma is rare and represents 0.5% of all new cancer cases in the United States. Hodgkin lymphoma is more common among young adults and among men than women and the average age at diagnosis is 39 years. In 2017, it is estimated to be 8,260 new cases of Hodgkin lymphoma in the United States.


Age-specific incidence of Hodgkin's Lymphoma, 2010–2014.

Source: National Cancer Institute. Bethesda, MD, USA



Incidence of Hodgkin's lymphoma, 1975–2014.

Source: National Cancer Institute. Bethesda, MD, USA

Oslo University Hospital shall not be liable for any loss whether direct, indirect, incidental or consequential, arising out of access to, use of, or reliance upon any of the content on this website. Oslo University Hospital© 2018